GSURX
Price
$64.93
Change
-$0.33 (-0.51%)
Updated
Aug 19 closing price
Net Assets
1.13B
VTSMX
Price
$153.12
Change
-$0.93 (-0.60%)
Updated
Aug 19 closing price
Net Assets
1.91T
Interact to see
Advertisement

GSURX vs VTSMX

Header iconGSURX vs VTSMX Comparison
Open Charts GSURX vs VTSMXBanner chart's image
Goldman Sachs US Equity Insights R
Price$64.93
Change-$0.33 (-0.51%)
VolumeN/A
Net Assets1.13B
Vanguard Total Stock Mkt Idx I
Price$153.12
Change-$0.93 (-0.60%)
VolumeN/A
Net Assets1.91T
GSURX vs VTSMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GSURX vs. VTSMX commentary
Aug 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSURX is a Buy and VTSMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 1.91T vs. GSURX (1.13B). VTSMX pays higher dividends than GSURX: VTSMX (1.09) vs GSURX (0.00). GSURX was incepted earlier than VTSMX: GSURX (18 years) vs VTSMX (33 years). GSURX (1.22) is less costly to investors than VTSMX (0.14). GSURX is a more actively managed with annual turnover of: 206.00 vs. VTSMX (2.00). GSURX has a lower initial minimum investment than VTSMX: GSURX (0) vs VTSMX (3000). VTSMX annual gain was more profitable for investors over the last year : 14.18 vs. GSURX (-2.36). VTSMX return over 5 years is better than : 83.88 vs. GSURX (18.21).
GSURXVTSMXGSURX / VTSMX
Total Expense Ratio1.180.14843%
Annual Report Gross Expense Ratio1.220.14871%
Fund Existence18 years33 years-
Gain YTD6.2868.64273%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.13B1.91T0%
Annual Yield % from dividends0.001.09-
Returns for 1 year-2.3614.18-17%
Returns for 3 years28.3048.9958%
Returns for 5 years18.2183.8822%
Returns for 10 years71.17219.5132%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENSG167.022.96
+1.80%
Ensign Group (The)
YMAB8.52N/A
N/A
Y-mAbs Therapeutics
BKV21.34-0.09
-0.42%
BKV Corp
OPAL2.25-0.04
-1.75%
OPAL Fuels
CYCCP4.81-1.10
-18.61%
Cyclacel Pharmaceuticals